Research Articles
How Switching Immune Cell Identity Fights Parasitic Infections: The Cathepsin B Story
Discover how cathepsin B inhibitors reprogram CD4+ T cell differentiation from Th2 to Th1 in leishmaniasis, offering new therapeutic approaches for parasitic infections.
Pathogen Reduction in Blood Banks: The Delicate Balance Between Safety and Function
Exploring the complex trade-offs in pathogen reduction technologies for blood bank components, balancing safety with functionality.
Shield and Sword: How Human Antibodies Could Stop Zika Virus in Its Tracks
Discover how neutralizing human monoclonal antibodies provide complete protection against Zika virus infection in macaque studies, offering promising therapeutic prospects.
The Body's Double Agents: How "Decoy" Antibodies Supercharge Our Defenses
Discover how co-precipitating antibodies work as strategic support units in our immune system to enhance defense against tetanus toxin.
The Double Burden: How Type 2 Diabetes Disrupts Immune Defense in Obesity
Explore how Type 2 Diabetes and obesity create a perfect storm that compromises immune function through chronic inflammation and metabolic dysregulation.
The Silent Invader: How Your Immune System Fights Mycobacterium Avium
Explore the complex battle between Mycobacterium avium and the human immune system, focusing on the critical role of type I cytokines in host defense mechanisms.
Tocilizumab: A Revolutionary Treatment for Rheumatoid Arthritis
Explore how Tocilizumab, an IL-6 receptor inhibitor, is revolutionizing rheumatoid arthritis treatment through targeted therapy and proven clinical efficacy.
The Unheard Invader: Rediscovering Tuberculosis of the Middle Ear
Exploring the resurgence of tuberculous otitis media, a rare middle ear infection that challenges modern diagnostics
Azithromycin and COVID-19: The Rise and Fall of a Pandemic Hope
The story of azithromycin's journey from potential COVID-19 treatment to rejected therapy reveals how science self-corrects during a global health crisis.
The Triple Threat: Could Combining Vedolizumab, Ustekinumab, and Tofacitinib Revolutionize Ulcerative Colitis Treatment?
Exploring the potential of vedolizumab, ustekinumab, and tofacitinib triple therapy for ulcerative colitis treatment through mechanisms, evidence, and future directions.